| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) | 
|---|
| 07/16/2013 | CA2583983C Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor  | 
| 07/16/2013 | CA2569826C Substituted 2-alkyl quinazolinone derivatives as parp inhibitors  | 
| 07/11/2013 | WO2013102929A1 Novel compounds for treatment of diabetes, obesity or related disorders  | 
| 07/11/2013 | WO2013102655A1 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis b  | 
| 07/11/2013 | WO2013102242A1 Heterocyclic compounds and methods for their use  | 
| 07/11/2013 | WO2013019079A3 Composition containing 5-hydroxyindole compounds or sponge scalarispongia sp. extracts as active ingredients for prevention and treatment of cancer diseases  | 
| 07/11/2013 | US20130178631 Novel alkynyl derivatives as modulators of metabotropic glutamate receptors  | 
| 07/11/2013 | US20130178625 P 2 x 4 receptor antagonist  | 
| 07/11/2013 | US20130178507 Substituted bicyclic hcv inhibitors  | 
| 07/11/2013 | US20130178475 sGC STIMULATORS  | 
| 07/11/2013 | US20130178471 Modulators of atp-binding cassette transporters  | 
| 07/11/2013 | US20130178462 Compounds for the reduction of beta-amyloid production  | 
| 07/11/2013 | US20130178443 Phenylquinazoline derivatives  | 
| 07/11/2013 | US20130178420 Novel glp-1 receptor modulators  | 
| 07/11/2013 | US20130178417 Novel nitrogen-containing heteroaryl compounds and methods of use thereof  | 
| 07/11/2013 | US20130177632 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents  | 
| 07/11/2013 | US20130175509 Condensed-cyclic compound and organic light emitting diode including the same  | 
| 07/10/2013 | EP2612860A1 Quinazoline derivatives substituted by aniline, preparation method and use thereof  | 
| 07/10/2013 | EP2611806A1 Deuterium-enriched heterocyclic compounds as kinase inhibitors  | 
| 07/10/2013 | EP2611798A1 Pyridazinones, method of making, and method of use thereof  | 
| 07/10/2013 | EP2611797A2 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells  | 
| 07/10/2013 | EP2611796A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof  | 
| 07/10/2013 | EP2611795A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof  | 
| 07/10/2013 | EP2611794A1 4-azolylaminoquinazoline derivatives and methods of use thereof  | 
| 07/10/2013 | EP2611793A1 2-cycloquinazoline derivatives and methods of use thereof  | 
| 07/10/2013 | EP2611792A1 Hydrobromide salts of a pyrazolylaminoquinazoline  | 
| 07/10/2013 | EP2611791A1 Oligooxopiperazines and methods of making and using them  | 
| 07/10/2013 | EP2611790A1 Pyridinones/pyrazinones, method of making, and method of use thereof  | 
| 07/10/2013 | EP2611789A1 Quinazoline compounds and methods of use thereof  | 
| 07/10/2013 | EP2611786A1 New compositions and methods for controlling nematode pests  | 
| 07/10/2013 | EP2611774A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors  | 
| 07/10/2013 | EP2611772A1 2 - (benzyloxy) benzamides as lrrk2 kinase inhibitors  | 
| 07/10/2013 | EP2611502A1 Adenosine a3 receptor modulating compounds and methods of use thereof  | 
| 07/10/2013 | EP2611448A1 7-cyclylquinazoline derivatives and methods of use thereof  | 
| 07/10/2013 | EP2611300A1 Substituted fused pyrimidinones and dihydropyrimidinones  | 
| 07/10/2013 | EP2611297A1 Fungicidal pyrazoles  | 
| 07/10/2013 | CN103201277A Pyridazinones, method of making, and method of use thereof  | 
| 07/10/2013 | CN103201276A Indole derivatives  | 
| 07/10/2013 | CN103201274A Pyrrolidine derivatives used as cathepsin inhibitors  | 
| 07/10/2013 | CN103201270A P2x4 receptor antagonist  | 
| 07/10/2013 | CN103201268A Novel piperazine analogs as broad-spectrum influenza antivirals  | 
| 07/10/2013 | CN103193766A Cyan and aryl-pyrazole fluorouracil compound as well as preparation method and application thereof  | 
| 07/10/2013 | CN103191120A Application of pyrimidine derivative in preparation of drugs capable of prevention and/or treatment and/or adjuvant therapy of tumors  | 
| 07/10/2013 | CN101910142B Modulators for beta-amyloid  | 
| 07/10/2013 | CN101781286B Method for preparing candesartan cilexetil  | 
| 07/10/2013 | CN101687841B Benzimidazole derivatives  | 
| 07/10/2013 | CN101679242B Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof  | 
| 07/10/2013 | CN101367794B Preparation method for quinazoline derivants and medical uses thereof  | 
| 07/09/2013 | US8481750 Derivatives of 6,7-dihydro-5H-imidazo[1,2-α]imidazole-3-carboxylic acid amides  | 
| 07/09/2013 | US8481733 Substituted imidazopyr- and imidazotri-azines  | 
| 07/09/2013 | US8481731 Compounds, pharmaceutical composition and methods relating thereto  | 
| 07/09/2013 | US8481730 Method of synthesis of Bosentan, its polymorphic forms and its salts  | 
| 07/09/2013 | US8481726 Process for the preparation of sterically hindered nitroxyl ethers  | 
| 07/09/2013 | US8481564 Inhibitors of c-fms kinase  | 
| 07/09/2013 | US8481548 2-[4-(2-chloro-pyridin-4-ylethynyl)-2-methyl-imidazol-1-yl]-4-trifluoromethyl-pyrimidine; metabotropic glutamate (mGluR5) receptor antagonist; analgesic, neurodegenerative diseases; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain  | 
| 07/09/2013 | US8481542 Pyridazinyl derivatives as smo inhibitors  | 
| 07/09/2013 | US8481539 Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same  | 
| 07/09/2013 | US8481537 Caspase inhibitors based of pyridazinone scaffold  | 
| 07/09/2013 | US8481536 Benzotriazine inhibitors of kinases  | 
| 07/09/2013 | US8481535 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor  | 
| 07/09/2013 | US8481494 Compounds for the treatment of diseases related to protein misfolding  | 
| 07/09/2013 | CA2761440C Fredericamycin derivatives  | 
| 07/09/2013 | CA2580610C Diaminotriazole compounds useful as protein kinase inhibitors  | 
| 07/09/2013 | CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4  | 
| 07/09/2013 | CA2520323C Tie-2 modulators and methods of use  | 
| 07/09/2013 | CA2408408C Modulators of tnf- alpha signaling  | 
| 07/04/2013 | WO2013102059A1 Pyrazolo [3, 4-d] pyrimidine and pyrrolo [2, 3-d] pyrimidine compounds as kinase inhibitors  | 
| 07/04/2013 | WO2013101911A2 Benzimidazole derivatives as selective blockers of persistent sodium current  | 
| 07/04/2013 | WO2013101830A1 2 - benzyl, 3 - (pyrimidin- 2 -yl) substituted pyrazoles useful as sgc stimulators  | 
| 07/04/2013 | WO2013098375A1 New azetidine derivatives, pharmaceutical compositions and uses thereof  | 
| 07/04/2013 | WO2013098373A1 New azetidine derivatives, pharmaceutical compositions and uses thereof  | 
| 07/04/2013 | WO2013098320A1 Quinazolinone derivatives as hcv inhibitors  | 
| 07/04/2013 | WO2013098313A1 Hetero-bicyclic derivatives as hcv inhibitors  | 
| 07/04/2013 | WO2013055949A3 Pyrazol-3-ones that activate pro-apoptotic bax  | 
| 07/04/2013 | WO2013019561A8 Nuclear transport modulators and uses thereof  | 
| 07/04/2013 | US20130172570 Method of making benzazoles  | 
| 07/04/2013 | US20130172556 Method for producing pyridazinone compounds and intermediate thereof  | 
| 07/04/2013 | US20130172389 Benzimidazole derivatives as selective blockers of persistent sodium current  | 
| 07/04/2013 | US20130172384 Fatty acid synthase inhibitors  | 
| 07/04/2013 | US20130172365 Arylosulfonamides for the treatment of cns diseases  | 
| 07/04/2013 | US20130172352 5-membered heterocycle-based p38 kinase inhibitors  | 
| 07/04/2013 | US20130172351 Dihydropyrazoles  | 
| 07/04/2013 | US20130172335 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds  | 
| 07/04/2013 | US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c  | 
| 07/04/2013 | US20130172317 Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same  | 
| 07/04/2013 | US20130172316 New azetidine derivatives, pharmaceutical compositions and uses thereof  | 
| 07/04/2013 | US20130172315 Substituted anilines as ccr(4) antagonists  | 
| 07/04/2013 | US20130172312 Azetidine Derivatives  | 
| 07/04/2013 | US20130171515 Anode material and anode electrode plate  | 
| 07/04/2013 | DE112010005848T5 Amidverbindungen Amide compounds  | 
| 07/04/2013 | CA2861013A1 New azetidine derivatives, pharmaceutical compositions and uses thereof  | 
| 07/03/2013 | EP2610247A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonists  | 
| 07/03/2013 | EP2610244A1 Indole compounds  | 
| 07/03/2013 | EP2609078A1 Hydroxamate-based inhibitors of deacetylases  | 
| 07/03/2013 | EP2608671A1 Compounds for treatment of cancer  | 
| 07/03/2013 | CN103189371A Novel inhibitors of hepatitis C virus  | 
| 07/03/2013 | CN103189370A Triazole derivatives as ligands for GABA receptors  | 
| 07/03/2013 | CN103189369A Pyridinones/pyrazinones, method of making, and method of use thereof  | 
| 07/03/2013 | CN103189363A Bisaryl-bonded aryltriazolones and use thereof  | 
| 07/03/2013 | CN103189353A Hydroxamate-based inhibitors of deacetylases  |